Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 298 of 2647 -
Wednesday, December 31 2025 | 04:11:55 AM

Elauwit Announces Pricing of $15.0 Million Initial Public Offering

Columbia, South Carolina–(Newsfile Corp. – November 4, 2025) – Elauwit Connection, Inc. (“Elauwit” or the “Company“) today announced the pricing of its firm commitment initial public offering of an aggregate of 1,667,000 shares of its common stock (the “Offering“) at $9.00 per share. The gross proceeds to Elauwit from the …

Read More »

Sphere 3D Reports Third Quarter 2025 Financial Results

Stamford, Connecticut–(Newsfile Corp. – November 4, 2025) – Sphere 3D Corp. (NASDAQ: ANY) (“Sphere 3D” or the “Company”), a Bitcoin mining company, today reported financial results for the third quarter of fiscal year 2025 ended September 30, 2025. COMMENTS FROM SPHERE 3D LEADERSHIP “This quarter reflects continued progress in strengthening …

Read More »

Rize Oncology Announces Completion of Private Placement and Resignation of Director

Kelowna, British Columbia–(Newsfile Corp. – November 4, 2025) – Rize Oncology Inc. (OTC: RZONF) (the “Company“), a clinical-stage pharmaceutical company focused on developing innovative oncology therapeutics, is pleased to announce that on October 30, 2025 it completed a non-brokered private placement (the “Private Placement“) of units of the Company (the …

Read More »

Suncor Energy increases dividend

All financial figures are in Canadian dollars. Calgary, Alberta–(Newsfile Corp. – November 4, 2025) – Suncor Energy’s (TSX: SU) (NYSE: SU) Board of Directors has approved a quarterly dividend of $0.60 per common share, representing an approximate 5% increase over the prior quarterly dividend. “Through continued operational improvements that have …

Read More »

Hemostemix Closes Private Placement of $461,230

Calgary, Alberta–(Newsfile Corp. – November 4, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from pain related to angina, peripheral arterial disease, chronic limb threatening ischemia, ischemic cardiomyopathy, non-ischemic dilated …

Read More »

Myriad Uranium Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$7.5 Million

Vancouver, British Columbia–(Newsfile Corp. – November 4, 2025) – Myriad Uranium Corp. (CSE: M) (FSE: C3Q) (“Myriad” or the “Company”) is pleased to announce that as a result of strong investor demand, the Company has increased the size of its previously announced “bought deal” private placement (the “Underwritten Offering“) from …

Read More »

CSE Bulletin: Suspensions – CMT, GAND, SASY

Toronto, Ontario–(Newsfile Corp. – Le 4 novembre/November 2025) – Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions. For more information …

Read More »